Abstract: A method of making high performance concrete, the method may include adding ground glass powder (GP), nanosilica (nS) powder, cement, silica fume, fly ash, and sand to create a homogenized mixture. The method may also include homogenizing the mixture by mixing and adding water and superplasticizer to the homogenized mixture to obtain a slurry. The method may also include mixing the slurry until a high flowability mixture is obtained. The method may then include adding a first microsteel fiber (T1) to the high flowability mixture; adding a second microsteel fiber (T3) to the high flowability mixture; adding a third microsteel fiber (T4) to the high flowability mixture; and casting the high flowability mixture.

Abstract: A self-biased, closed loop, low current free running oscillator clock generator method and apparatus are provided with a current mode comparator connected to a trimming resistor and configured to compare an internally generated voltage reference VREF signal to a voltage feedback signal VFB, where the current mode comparator comprises a common gate amplifier connected to a current mirror circuit in a negative self-biased closed loop to generate a control current signal for controlling a current controlled oscillator to produce an output clock signal having a clock frequency based on the control current signal, where a frequency-to-voltage converter is connected in a feedback path to receive the output clock signal and is configured to produce the voltage feedback signal VFB for input to the current mode comparator, wherein the clock frequency of the output clock signal is tuned to a nominal locked output frequency fOUT by the trimming resistor.

Abstract: A method of making nanosilica from glass, the method comprising: gathering glass waste; grinding the glass waste to obtain a glass powder containing nanoparticles; adding the glass powder containing the nanoparticles to a water solution comprising a dispersing agent to obtain a colloidal system containing nanoparticles; separating the nanoparticles from the colloidal system to obtain separated nanoparticles; and drying the separated nanoparticles to obtain nanosilica.

Abstract: The present invention relates to a Golf Swing Tracker Carpet Mat designed for assisting golfers in improving their swing technique. The mat comprising tufted fiber yarns anchored by primary and secondary backings. When a golf club interacts with the mat, the fibers demonstrate a visual change due to a pile shading effect, simulating the appearance of a divot, and providing immediate feedback on the golfer's swing path and strike quality. The mat also features an alignment guidance pattern and is encapsulated within an anti-skid base for stability. Furthermore, the mat offers variations in tufting patterns, densities, and fiber lengths, enabling it to mimic different golf course terrains, providing a tailored practice experience for the user.

Abstract: The present disclosure relates to a method of making nanoparticles from glass, the method including: gathering glass waste; hammering the glass waste into ready to grind pieces; adding an amount of the ready to grind pieces into a grinding bowl; adding steel balls to the grinding bowl; grinding the ready to grind pieces; and obtaining a powder containing the nanoparticles.

Abstract: An ultra-high performance concrete (UHPC) including empty quarter desert sand (EQS) and micro-steel fibers (HyTUHPC). The ultra-high performance concrete (UHPC) can have a high viscosity due to the presence of EQS.

Abstract: Systems and methods for providing temperature compensation in oscillators circuits are discussed. In various embodiments, these systems and methods may be implemented in technologies where only resistors with the same type (positive or negative) of temperature coefficients of resistance are available. For example, in some implementations, an oscillator circuit may include a voltage generator coupled to an input terminal of a common gate amplifier through a first resistor, and a frequency-to-voltage converter coupled to another input terminal of the common gate amplifier through a second resistor, where the second resistor may be configured to reduce a frequency variation of the oscillator circuit in response to temperature changes.

Abstract: Various embodiments disclose a method comprising receiving, by a computing device, metrology data indicating consumption of a plurality of utility commodities at a location, determining, by the computing device based on the metrology data, that the location is not occupied, determining, by the computing device, that the metrology data indicates that consumption of a first utility commodity of the plurality of utility commodities is atypical, and in response to determining that the location is not occupied and that consumption of the first utility commodity is atypical, performing, by the computing device, a responsive action.

Abstract: A self-biased, closed loop, low current free running oscillator clock generator method and apparatus are provided with a current mode comparator connected to a trimming resistor and configured to compare an internally generated voltage reference VREF signal to a voltage feedback signal VFB, where the current mode comparator comprises a common gate amplifier connected to a current mirror circuit in a negative self-biased closed loop to generate a control current signal for controlling a current controlled oscillator to produce an output clock signal having a clock frequency based on the control current signal, where a frequency-to-voltage converter is connected in a feedback path to receive the output clock signal and is configured to produce the voltage feedback signal VFB for input to the current mode comparator, wherein the clock frequency of the output clock signal is tuned to a nominal locked output frequency fOUT by the trimming resistor.

Abstract: The present disclosure is concerned with substituted N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds, and methods of treating and/or preventing neurodegenerative or neurocognitive disorders including, but not limited to, Alzheimer's disease, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL), Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease), Multiple Sclerosis, spinal muscular atrophy, spinal and bulbar muscular atrophy, familial spastic paraparesis, Machado Joseph disease, Friedreich's ataxia, Lewy body disease, and dementia (e.g., vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, dementia induced by Alzheimer's disease or Parkinson's disease). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present intervention identifies the antiglycating inhibitors from a series of carbazole-linked 1,2,3 triazole derivatives through in vitro MGO-mediated glycating BSA model. Derivatives 12, and 13 established a remarkable antiglycation activity at the receptor level in human monocytes. These compounds were found non-toxic, and possess the potential to halt AGE-RAGE/ROS-mediated NF-kB-dependent COX-2, and its proinflammatory product, PGE2, production in monocytes. Hence, carbazole-linked 1,2,3 triazole derivatives provide treatment modalities to delay or prevent the onset of late diabetic micro- and macro-vascular complications in diabetic patients.

Abstract: The cementitious mixture includes cement with a concentration of between about 5 wt % and about 20 wt %; powdered glass with a concentration of between about 5 wt % and about 35 wt %; fly ash with a concentration of between about 20 wt % and about 40 wt %; sand with a concentration of between about 18 wt % and about 25 wt %; a poly(carboxylate ether)-based superplasticizer with a concentration of between about 0.8 wt % and about 1.2 wt %; and water with a concentration of between about 14 wt % and about 16 wt %. Alternatively, the fly ash may be replaced with ground granulated blast furnace slag (GGBFS). The powdered glass is preferably powdered recycled glass cullet. The glass cullet may be ground to have an average particle size of about 10 ?m or less. The sand may be red dune sand, and the cement may be Portland cement or white cement. The cementitious may also include polyvinyl alcohol (PVA) microfibers.

Abstract: A method for calibrating an animation includes obtaining a static source image of a source face; capturing, by an image capturing device, a driving video of a human; determining whether a driving face, of the human, is present in each of the video frames; measuring a driving face position and a driving face size in a calibration reference frame of the driving video; generating each of one or more modified video frames based on the calibration reference frame and each of one or more subsequent video frames; and outputting, for each of the driving video frames, the source image in response to determining that the driving face is not present, and outputting the source image and the modified video frame in response to determining that the driving face is present.

Abstract: A method for calibrating an animation includes obtaining a static source image of a source face; capturing, by an image capturing device, a driving video of a human; determining whether a driving face, of the human, is present in each of the video frames; measuring a driving face position and a driving face size in a calibration reference frame of the driving video; generating each of one or more modified video frames based on the calibration reference frame and each of one or more subsequent video frames; and outputting, for each of the driving video frames, the source image in response to determining that the driving face is not present, and outputting the source image and the modified video frame in response to determining that the driving face is present.

Abstract: The present intervention identifies the antiglycating inhibitors from a series of carbazole-linked 1,2,3 triazole derivatives through in vitro MGO-mediated glycating BSA model. Derivatives 12, and 13 established a remarkable antiglycation activity at the receptor level in human monocytes. These compounds were found non-toxic, and possess the potential to halt AGE-RAGE/ROS- mediated NF- kB-dependent COX-2, and its proinflammatory product, PGE2, production in monocytes. Hence, carbazole-linked 1,2,3 triazole derivatives provide treatment modalities to delay or prevent the onset of late diabetic micro- and macro-vascular complications in diabetic patients.

Abstract: The present disclosure is concerned with substituted N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds, and methods of treating and/or preventing neurodegenerative or neurocognitive disorders including, but not limited to, Alzheimer's disease, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL), Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease), Multiple Sclerosis, spinal muscular atrophy, spinal and bulbar muscular atrophy, familial spastic paraparesis, Machado Joseph disease, Friedreich's ataxia, Lewy body disease, and dementia (e.g., vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, dementia induced by Alzheimer's disease or Parkinson's disease). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.